NEW YORK (GenomeWeb) – Genome BC said today that it is investing C$750,000 ($586,000) in Microbiome Insights (MBI), a Vancouver-based microbiome testing company.
MBI provides next-generation sequencing-based analytical testing and consulting services to microbiome researchers in academia and industry.